Julia Perez-Baz

Title: Julia Perez-Baz: Innovator in Antitumor Compounds

Introduction

Julia Perez-Baz is a prominent inventor based in Leon, Spain. She has made significant contributions to the field of biotechnology, particularly in the development of novel antitumor compounds. With a total of 2 patents, her work is recognized for its potential impact on cancer treatment.

Latest Patents

Julia's latest patents include groundbreaking research on polycyclic xanthones and macrolides with antitumor activity. The first patent focuses on a new class of antitumor compounds isolated from a marine microbe, strain PO13-046. This compound, designated IB-00208, demonstrates interesting activity against several cancer cell lines and Gram-positive bacteria. The second patent involves the compound IB-96212, derived from cultivating the strain of Micromonospora sp. ES25-008. This compound can be hydrolyzed to produce IB-96212B, showcasing the versatility of sugar substituents in its structure.

Career Highlights

Julia is currently employed at Instituto Biomar, S.A., where she continues her innovative research. Her work has garnered attention in the scientific community, contributing to advancements in cancer therapeutics.

Collaborations

Julia collaborates with esteemed colleagues, including Francisco Romero and Fernando Espliego. Their combined expertise enhances the research efforts at Instituto Biomar, S.A.

Conclusion

Julia Perez-Baz is a trailblazer in the field of biotechnology, with her innovative patents paving the way for new cancer treatments. Her dedication to research and collaboration exemplifies the spirit of innovation in the scientific community.